Learning Objectives:

1.  Describe an "armed" oncolytic virus approach with potential to reprogram TME and counteract multiple immune resistance mechanisms.

2. How indoleamine 2,3 dioxygenase (IDO) represents a potent metabolic immune checkpoint beyond generation KYN.

3. 

Session date: 
Wednesday, May 12, 2021 - 8:00am to 9:00am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Adekunle Odunsi, MD, PhD